Samsung continues its expansion in the healthcare business by entering into a joint venture with US-based Quintiles Transnational Corp. Samsung will invest 300 billion won or US$266 million and will setup a plant in Songdo district of Incheon, near Seoul to produce biopharmaceutical drugs for cancer and arthritis. Samsung Electronics and Samsung Everland will […]